The penitentiary treatment, is, together with security in prisons, one of the necessary pillars to be able to fulfill the constitutional mandate included in the 25.2 article of the Spanish Constitution. Currently, there is a wide variety of programs to intervene the deficiencies and needs of the inmates, for example, drug addiction, gender violence offenders, sexual offenders, violent behavior, addiction to gambling, among others. This article aims to bring the treatment work of the prison closer to the reader. The focus of this paper is on briefly explaining three of them, Sexual Assault Control Program (PCAS), Integral Attention to Mentally-ill Persons Program (PAIEM) and Therapeutic and Educational Units (UTEs). Finally, we can add some conclusions about the penitentiary treatment programs, some limitations and possible solutions.

This is a case report of a 73-year-old man with new-onset acute renal failure while being investigated for pulmonary infiltrates and mediastinal lymphadenopathies. Urine tests showed tubular range proteinuria with no microhaematuria. Immunology tests showed elevated serum IgG and hypocomplementaemia (classical pathway activation). Renal biopsy and clinical-pathological correlation were crucial in this case, reinforcing their important role in the final diagnosis of acute kidney injury.

IntroductionA major clinical challenge in treating allergic contact dermatitis (ACD) is that the first line of treatment is based on the use of corticosteroids. In this study, we aimed to develop a formulation that is devoid of steroids.MethodsWe used mouse ears treated with dinitrofluorobenzene (DNFB) to induce ACD. The efficacy of the test formulation to ameliorate and to prevent induced ACD was determined.ResultsTo treat this experimentally induced ACD, we developed a formulation containing BIPxine (a mixture of Rosa moschata and Croton lechleri (antioxidants) and Aloe vera and d-panthenol (moisturizers), and hydroglycolic solutions of disodium cromoglycate. Our results show that clear inhibition of ACD took place. The target of this formulation was PAR-2, TRPV4, and other mediators of the inflammatory and pain responses. However, this formulation must be evaluated in other models besides the mouse to confirm its effectiveness.ConclusionThe formulation presented here may provide new ACD therapies that do not involve the use of corticosteroids.Electronic supplementary materialThe online version of this article (10.1007/s13555-018-0223-8) contains supplementary material, which is available to authorized users.

No abstract

This paper deals with some Collembola from a cave at La Sierra de Grazalema (Málaga). In total, eight species of springtails were found. Two may represent new species but there is insufficient material available to prepare full descriptions (one species in the genus Ceratophysella, one in Hypogastrura), one species (Folsomides cf. ayllonensis) is identified to species, but differences from the nominal species suggest further studies may indicate the Grazalema populations represent a distinct form, and one other is described as new to science, Entomobrya virginiae Arbea, sp. nov. The new species is characterized by no sexual dimorphism in colour pattern, 5 central macrochaetae on Abd II and 4 macrochaetae on Abd III. For the identification and description of the new species, the set of characters proposed by Jordana and Baquero (2005) was used.